|
AZYO | Elutia Inc. |
|
|
AZYO | Elutia Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ -1.16 |
| Leverage | 249.35% |
| Market Cap | $ 37.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -26.3m |
| Margin | -131.67% |